Stem Pharm biomaterials can serve as optimal substrates or matrices for expansion of functional human cells for therapeutic applications. These biomaterials can be used for more efficient expansion of human cells in both scale-up and scale-out cell manufacturing.
Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are in use in over 600 ongoing clinical trials for diseases ranging from stroke to Crohn’s disease. Stem Pharm’s proprietary technologies can expand functional human MSCs in serum-free medium.
Pluripotent Stem Cells
A variety of emerging cell and tissue therapies are based on human induced pluripotent stem cells (iPSCs). Stem Pharm's proprietary technologies can be used to more efficiently expand iPSCs and iPSC-derived cells, and to enhance differentiation of iPSCs to become cell types of particular therapeutic relevance.
Novel Therapeutic Cells
Stem Pharm’s ability to customize biomaterials as substrates or matrices for cell expansion and differentiation has resulted in expansion of unique therapeutic cells. To learn more about how our biomaterials could advance your therapeutic program, please contact us.